Early Advocacy of Future Drugs

Being an early advocate for emerging drugs is a strategically favorable position, as these substances are anticipated to gain universal acceptance in the coming decade. Emphasizing the importance of early adoption over criticism is crucial, as historical resistance to innovations like social media has shown. While concerns about the implementation of new technologies or drugs are valid, the trajectory towards widespread use is inevitable, and active engagement with these developments is preferable to negativity. Furthermore, there is an acknowledgment that at least two classes of drugs are expected to revolutionize healthcare similarly to GLPs, underscoring the importance of promoting these advancements thoughtfully and with proper medical guidance.